• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童高脂血症筛查。英国高脂血症协会的建议。

Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association.

作者信息

Wray R, Neil H, Rees J

机构信息

Conquest Hospital, St Leonards-on-Sea, Sussex.

出版信息

J R Coll Physicians Lond. 1996 Mar-Apr;30(2):115-8.

PMID:8709055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5401547/
Abstract

Children with familial hypercholesterolaemia are at high risk of developing coronary artery disease in early adulthood. The diagnosis should therefore be made in childhood. Population screening identifies a small number of children with major genetically determined disorders of lipid metabolism and a large number with polygenic hypercholesterolaemia of uncertain prognostic significance. Selective screening based on a family history of familial hypercholesterolaemia or premature coronary artery disease is an appropriate strategy for identifying most children with familial hypercholesterolaemia. A non-fasting total cholesterol measurement is a suitable screening test: if the concentration exceeds 5.5 mmol/l, a fasting measurement of total cholesterol, high-density lipoprotein cholesterol and triglyceride is required. The diagnosis in a child under 16 years should be based on finding a total cholesterol concentration greater than 6.7 mmol/l and a low-density lipoprotein cholesterol concentration above 4.0 mmol/l on at least two measurements taken more than one month apart. Children should not usually be screened before the age of two years, but the aim should be to diagnose heterozygous familial hypercholesterolaemia before the age of 10 years. Affected children should be referred for specialist care.

摘要

患有家族性高胆固醇血症的儿童在成年早期患冠状动脉疾病的风险很高。因此,诊断应在儿童期进行。人群筛查可识别出少数患有主要由基因决定的脂质代谢紊乱的儿童,以及大量患有预后意义不确定的多基因高胆固醇血症的儿童。基于家族性高胆固醇血症或早发性冠状动脉疾病家族史的选择性筛查是识别大多数家族性高胆固醇血症儿童的合适策略。非空腹总胆固醇测量是一种合适的筛查试验:如果浓度超过5.5 mmol/l,则需要空腹测量总胆固醇、高密度脂蛋白胆固醇和甘油三酯。16岁以下儿童的诊断应基于至少两次间隔一个多月测量的总胆固醇浓度大于6.7 mmol/l和低密度脂蛋白胆固醇浓度高于4.0 mmol/l。儿童通常不应在两岁之前进行筛查,但目标应是在10岁之前诊断出杂合子家族性高胆固醇血症。受影响的儿童应转诊接受专科护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c1/5401547/e02a3cb3b018/jrcollphyslond90376-0021-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c1/5401547/e02a3cb3b018/jrcollphyslond90376-0021-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c1/5401547/e02a3cb3b018/jrcollphyslond90376-0021-a.jpg

相似文献

1
Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association.儿童高脂血症筛查。英国高脂血症协会的建议。
J R Coll Physicians Lond. 1996 Mar-Apr;30(2):115-8.
2
Familial hypercholesterolaemia: pilot study to identify children at risk.家族性高胆固醇血症:识别高危儿童的初步研究。
J Clin Pathol. 1993 Aug;46(8):730-3. doi: 10.1136/jcp.46.8.730.
3
Lipid screening: is it enough to measure total cholesterol concentration?血脂筛查:测量总胆固醇浓度就足够了吗?
BMJ. 1990 Sep 22;301(6752):584-7. doi: 10.1136/bmj.301.6752.584.
4
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.高密度脂蛋白胆固醇水平及总胆固醇/高密度脂蛋白胆固醇比值作为分子定义的杂合子家族性高胆固醇血症中冠心病危险因素的重要性。
Eur Heart J. 2001 Mar;22(6):465-71. doi: 10.1053/euhj.2000.2408.
5
Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.法国某单一中心 53 例纯合子家族性高胆固醇血症患者的长期预后。
Atherosclerosis. 2017 Feb;257:130-137. doi: 10.1016/j.atherosclerosis.2017.01.015. Epub 2017 Jan 16.
6
Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.杂合子家族性高胆固醇血症中的冠状动脉疾病与止血变量
Br Heart J. 1985 Mar;53(3):265-8. doi: 10.1136/hrt.53.3.265.
7
Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.高危脂蛋白谱检测及血脂异常治疗指南。加拿大脂蛋白会议血脂异常指南特设委员会。
CMAJ. 1990 Jun 15;142(12):1371-82.
8
Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.用于检测儿童家族性高胆固醇血症的脂质和脂蛋白参数。DECOPIN项目。
Clin Investig Arterioscler. 2018 Jul-Aug;30(4):170-178. doi: 10.1016/j.arteri.2017.12.003. Epub 2018 Mar 27.
9
The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.成人高脂血症的识别与管理:欧洲动脉粥样硬化学会政策声明
Eur Heart J. 1988 May;9(5):571-600.
10
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.杂合子家族性高胆固醇血症患者的致病突变与早发性心血管疾病
Eur J Prev Cardiol. 2017 Jul;24(10):1051-1059. doi: 10.1177/2047487317702040. Epub 2017 Mar 29.

引用本文的文献

1
Statins for children with familial hypercholesterolemia.用于家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD006401. doi: 10.1002/14651858.CD006401.pub5.
2
Statins for children with familial hypercholesterolemia.用于患有家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4.
3
Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.

本文引用的文献

1
Pathogenesis of coronary disease in American soldiers killed in Korea.在朝鲜阵亡的美国士兵冠心病的发病机制
J Am Med Assoc. 1955 Jul 16;158(11):912-4. doi: 10.1001/jama.1955.02960110018005.
2
The psychological functioning of children with hypercholesterolemia and their families. A preliminary investigation.高胆固醇血症患儿及其家庭的心理功能:一项初步调查。
Clin Pediatr (Phila). 1993 Mar;32(3):135-41. doi: 10.1177/000992289303200302.
3
Familial hypercholesterolaemia: pilot study to identify children at risk.家族性高胆固醇血症:识别高危儿童的初步研究。
针对家族性高胆固醇血症的饮食干预措施(植物甾醇、甾烷醇、ω-3脂肪酸、大豆蛋白和膳食纤维)。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD001918. doi: 10.1002/14651858.CD001918.pub3.
4
Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.考来维仑在青少年和儿童杂合子家族性高胆固醇血症管理中的作用。
Adolesc Health Med Ther. 2010 Aug 4;1:53-60. doi: 10.2147/AHMT.S9272. eCollection 2010.
5
Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.儿科患者的高脂血症:降脂治疗在临床实践中的作用。
Drug Saf. 2010 Feb 1;33(2):115-25. doi: 10.2165/11319490-000000000-00000.
6
Screening relatives of patients with premature coronary heart disease.筛查早发性冠心病患者的亲属。
Heart. 2002 Apr;87(4):390-4. doi: 10.1136/heart.87.4.390.
7
ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.《内科学年鉴》简讯第151期:1997年9月。血脂异常的调查。
J Clin Pathol. 1997 Sep;50(9):721-34. doi: 10.1136/jcp.50.9.721.
8
The genetic testing of children.儿童的基因检测。
J R Soc Med. 1997 Aug;90(8):419-21. doi: 10.1177/014107689709000802.
9
A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.治疗儿童高胆固醇血症的合理方法。权衡风险与益处。
Drug Saf. 1997 May;16(5):330-41. doi: 10.2165/00002018-199716050-00004.
J Clin Pathol. 1993 Aug;46(8):730-3. doi: 10.1136/jcp.46.8.730.
4
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.高脂血症的管理:英国高脂血症协会指南
Postgrad Med J. 1993 May;69(811):359-69. doi: 10.1136/pgmj.69.811.359.
5
Serial analysis of plasma lipids and lipoproteins from individuals 9-21 y of age.对9至21岁个体的血浆脂质和脂蛋白进行系列分析。
Am J Clin Nutr. 1993 Jul;58(1):61-7. doi: 10.1093/ajcn/58.1.61.
6
Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study.儿童期血清脂质和脂蛋白测量的追踪及预测性:一项12年随访研究。芬兰年轻人心血管风险研究。
Am J Epidemiol. 1994 Dec 15;140(12):1096-110. doi: 10.1093/oxfordjournals.aje.a117210.
7
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).4444例冠心病患者降胆固醇随机试验:斯堪的纳维亚辛伐他汀生存研究(4S)
Lancet. 1994 Nov 19;344(8934):1383-9.
8
Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine.
Lancet. 1980 Oct 25;2(8200):873-5. doi: 10.1016/s0140-6736(80)92044-9.
9
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.血清胆固醇、脂蛋白与冠心病风险。弗雷明汉姆研究。
Ann Intern Med. 1971 Jan;74(1):1-12. doi: 10.7326/0003-4819-74-1-1.
10
Prospective study of serum cholesterol levels during first year of life.一岁内血清胆固醇水平的前瞻性研究。
Br Med J. 1972 Jun 17;2(5815):685-8. doi: 10.1136/bmj.2.5815.685.